Publication Name	World Journal of Gastroenterology
Manuscript ID	34134
Country	Italy

Received	2017-03-29 09:59
Peer-Review Started	2017-04-01 17:53
To Make the First Decision	2017-06-05 00:27
Return for Revision	2017-06-11 10:20
Revised	2017-07-03 21:34
Second Decision	2017-07-28 02:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-08-02 07:09
Articles in Press	2017-08-02 07:09
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-08-15 07:29
Publish the Manuscript Online	2017-08-28 06:54

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions
Manuscript Source	Invited Manuscript
All Author List	Guido Giordano, Massimo Pancione, Nunzio Olivieri, Pietro Parcesepe, Marianna Velocci, Tania Di Raimo, Luigi Coppola, Giuseppe Toffoli and Mario Rosario D'Andrea
Funding Agency and Grant Number
Corresponding Author	Guido Giordano, MD, Medical Oncology Unit, San Filippo Neri Hospital, Roma 00135, Italy. giordano.guido81@gmail.com
Key Words	Nano albumin bound-paclitaxel; Pancreatic cancer; Metastatic disease; Gemcitabine; Folfirinox
Core Tip	In this article, we provide an updated and critical overview about the role of nano albumin bound (Nab)-paclitaxel in pancreatic cancer (PDAC) treatment based on the latest advances in preclinical and clinical research. Furthermore, we focus on the use of nab-paclitaxel within the context of metastatic PDAC treatment landscape and we discuss about future implications in the light of current clinical ongoing trials.
Publish Date	2017-08-28 06:54
Citation	Giordano G, Pancione M, Olivieri N, Parcesepe P, Velocci M, Di Raimo T, Coppola L, Toffoli G, D’Andrea MR. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions. World J Gastroenterol 2017; 23(32): 5875-5886
URL	http://www.wjgnet.com/1007-9327/full/v23/i32/5875.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i32.5875

Full Article (PDF)	WJG-23-5875.pdf
Full Article (Word)	WJG-23-5875.doc
Manuscript File	34134-Review.docx
Answering Reviewers	34134-Answering reviewers.pdf
Audio Core Tip	34134-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	34134-Conflict-of-interest statement.pdf
Copyright License Agreement	34134-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	34134-Language certificate.pdf
Peer-review Report	34134-Peer-review(s).pdf
Scientific Misconduct Check	34134-Scientific misconduct check.pdf
Scientific Editor Work List	34134-Scientific editor work list.pdf